Peripheral Bypass Trial for Completion Control
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Medistim ASA
- Study ID
- NCT06264843
- Status
- Recruiting
Conditions
- Chronic Limb-Threatening Ischemia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes — DEVICEIdentify and validate intraoperative TTFM and HFUS findings (e.g. threshold values of Mean Graft Flow (MGF), MGF capacity, flow curve pattern, morphological issues)
Study Details
The goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery below-knee and above ankle
Key Dates
- Start date
- Nov 14, 2024
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 450 participants (estimated)
Arms
- Arm: Patency of lower extremity vein bypass graftsPrimary patency of lower extremity vein bypass grafts at one year
Primary Outcome Measure
Primary graft patency rate [ Time Frame: at 1 year ]
Central Contacts
- Anne Waaler+4790892713
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California | San Francisco | California | 94143 |
Find similar trials in San Francisco, CA
By research site
Related Studies
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaRecruiting · LimFlow, Inc. · La Jolla, California
- Pivotal Trial of the Boomerang Catheter for pDVAEnrolling By Invitation · Aveera Medical, Inc. · Sylmar, California
- Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio
- Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee DiseaseRecruiting · R3 Vascular Inc. · New York, New York